Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Nature Communications|March 26, 2024
Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancersMolly Went, Amit Sud, Charlie Mills, et al.
Oncotarget|May 15, 2018
Combined linkage and association analysis of classical Hodgkin lymphomaAlastair Lawrie, Shuo Han, Amit Sud, et al.
Medrxiv : the Preprint Server for Health Sciences|April 17, 2023
Risk factors for eight common cancers revealed from a phenome-wide Mendelian randomisation analysis of 378,142 cases and 485,715 controlsMolly Went, Amit Sud, Charlie Mills, et al.
The Lancet. Oncology|May 13, 2023
Utility of polygenic risk scores in UK cancer screening: a modelling analysisCatherine Huntley, Bethany Torr, Amit Sud, et al.
American Journal of Human Genetics|June 2, 2009
The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1Dan Hanson, Philip G Murray, Amit Sud, et al.
Nature Genetics|February 13, 2026
Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer typesAndrew Everall, Avraam Tapinos, Aliah Hawari, et al.
Research Square|December 18, 2023
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinomaRichard Houlston, Richard Culliford, Sam Lawrence, et al.
Molecular Cancer Research : MCR|January 21, 2026
Contrasting features of papillary and chromophobe renal cell carcinoma revealed by whole genome sequencingRichard Culliford, Charlie Mills, Daniel Chubb, et al.
Nature Communications|July 15, 2024
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinomaRichard Culliford, Samuel E D Lawrence, Charlie Mills, et al.
Gut|August 29, 2020
Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling studyChey Loveday, Amit Sud, Michael E Jones, et al.
Pageof 7